Revolution Medicines, Inc.
Market Cap
$30.08B
P/E Ratio
-24.22
EPS
$-5.95
Dividend Yield
0.00%
52-Week Range
$34.00 — $155.70
Volume
2.28M
Avg Volume
2.87M
Beta
1.01
Get alerted when RVMD hits your target price.
Free — enter your email to get started
P/E (TTM)
-24.22
Forward P/E
—
PEG Ratio
1.66
P/S (TTM)
0.00
P/B (TTM)
17.13
P/FCF
-41.95
EV/EBITDA
-30.33x
EV/Sales
—
ROE (TTM)
-0.63%
ROA (TTM)
-0.48%
ROIC
-0.16%
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
0.00%
Debt/Equity
0.10
Current Ratio
7.14
EPS Growth (YoY)
-0.72%
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.14%
EPS Growth (5Y)
-0.24%
Sales Growth (3Y)
-0.49%
Sales Growth (5Y)
-0.39%
EPS Est (This Year)
$-6.65
EPS Est (Next Year)
$-5.89
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$10.65
Strong Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $116.50(-19.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
-105000
Outstanding Shares
193.32M
Float
173.99M
Free Float %
90.00%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-02-13
Employees
616
CEO
Mark A. Goldsmith
Index Membership
—
Website
https://www.revmed.com
Revolution Medicines, Inc. (RVMD) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $30.08B, a P/E ratio of -24.22, RVMD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare RVMD against other stocks using dozens of fundamental and technical filters.
Revolution Medicines, Inc. (RVMD) has a trailing twelve-month (TTM) P/E ratio of -24.22. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Revolution Medicines, Inc. (RVMD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Revolution Medicines, Inc. (RVMD) has a market capitalization of $30.08 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Strong Buy" rating on Revolution Medicines, Inc. (RVMD) with an average score of 1.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $116.50 implies 19.2% downside from the current price.